SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-063240
Filing Date
2022-05-20
Accepted
2022-05-20 11:19:09
Documents
3
Group Members
DANIEL EDWARD LLEWELLEN COOKSON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2216134d1_sc13da.htm SC 13D/A 47104
2 EXHIBIT 99.3 tm2216134d1_ex99-3.htm EX-99.3 18702
3 GRAPHIC tm2216134d1_ex99-3img001.jpg GRAPHIC 3340
  Complete submission text file 0001104659-22-063240.txt   72181
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Subject) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89971 | Film No.: 22946294
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE 2301, 23RD FLOOR API TRIO TOWER AL BARSHA 1 DUBAI C0 NA
Business Address OFFICE 2301, 23RD FLOOR API TRIO TOWER AL BARSHA 1 DUBAI C0 NA 00971555241459
All Blue Falcons FZE (Filed by) CIK: 0001925178 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A